In Depth 11 Nov 2024 Gene editing sector investment struggles: What’s driving the slowdown? Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs. November 11, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Nov 2024 The biggest private biotech investments in October 2024 The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024. November 7, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 6 Nov 2024 Tuberculosis research: Are we finally close to developing a more effective treatment option? Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options. November 6, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2024 Five T cell engager companies you should know about Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off. October 31, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies? Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies. October 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 25 Oct 2024 How biotech startups are trying to save the oceans with lab-grown fish Find out everything you need to know about lab-grown fish, including the startups trying to save the oceans with their products. October 25, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Oct 2024 Six biotech companies advancing multiple sclerosis therapies Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease. October 24, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 16 Oct 2024 JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer? Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer. October 16, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates Find out more about six biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human health. October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2024 12 biotech unicorns revolutionizing the future of healthcare Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the biopharma industry. October 10, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Oct 2024 The biggest private biotech investments in September 2024 The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024. October 4, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 2 Oct 2024 Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C. October 2, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email